Press releaseGlobe Newswire
Gain Therapeutics
GANX · NASDAQ
$1.19−$0.06 (−4.80%)TodayMarket closed ·
Prev close $1.25
Latest news
- Press releaseGlobe Newswire
Gain Therapeutics Presents Positive Phase 1b Open-Label Extension Data For Rexaceract Demonstrating Further Evidence of Disease-Modifying Activity Through 12 Months Administration
- Press releaseGlobe Newswire
Gain Therapeutics Announces Poster Presentation at International Congress of Parkinson’s Disease and Movement Disorders
- Press releaseGlobe Newswire
Gain Therapeutics to Participate at ROTH Fifth Annual Healthcare Opportunities Conference
- Press releaseGlobe Newswire
Gain Therapeutics to Participate at H.C. Wainwright 28th Annual Global Investment Conference
- Press releaseGlobe Newswire
Gain Therapeutics Reports Financial Results for Second Quarter 2026 and Provides Corporate Update
- News
Gain Therapeutics Issues CEO Letter; Expects To Fund Operations Into Q2 2027, Based On Current Operating Plans, Including Completion Of Phase 1B Open-Label Extension In October And Initiation Of A Phase 2 During Q3 2026
- Press releaseGlobe Newswire
Gain Therapeutics CEO Gene Mack Issues Letter to Shareholders and Provides Operational Update
- Press releaseGlobe Newswire
Gain Therapeutics Receives FDA Clearance of IND to Advance GT-02287 into Phase 2 Clinical Development for Parkinson’s Disease
- Press releaseGlobe Newswire
Gain Therapeutics to Present at H.C. Wainwright 7th Annual Neuro Perspectives Expert Summit
- Press releaseGlobe Newswire
Gain Therapeutics to Present at the 38th Annual ROTH Conference
- News
12 Health Care Stocks Moving In Wednesday's Intraday Session
- Press releaseGlobe Newswire
Gain Therapeutics to Present at Oppenheimer 36th Annual Healthcare Life Sciences Conference
- NewsAvi Kapoor
Why GH Research Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket
- Press releaseGlobe Newswire
Gain Therapeutics to Attend the 2025 Maxim Growth Summit
- News
12 Health Care Stocks Moving In Friday's After-Market Session
- NewsRishabh Mishra
US Futures Trade Mixed As June Inflation Ticks Up: ASML, Morgan Stanley, Goldman Sachs, BofA Earnings In Focus
- News
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
- News
12 Health Care Stocks Moving In Friday's Pre-Market Session
- News
12 Health Care Stocks Moving In Friday's After-Market Session
- Press releaseGlobe Newswire
Gain Therapeutics To Host Virtual Webinar on Results From Phase 1 Study and Design of Upcoming Phase 1b Trial of GT-02287, a Novel GCase-Targeting Small Molecule Therapy for Parkinson's Disease
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.